Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members
- 1 March 2017
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 389, 59-69
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (MCO – 9998)
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 39 references indexed in Scilit:
- Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterizationBioorganic & Medicinal Chemistry, 2012
- The transcriptional landscape and mutational profile of lung adenocarcinomaGenome Research, 2012
- Identification of the human testis protein phosphatase 1 interactomeBiochemical Pharmacology, 2011
- Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargoOncogene, 2011
- BIM Expression in Treatment-Naïve Cancers Predicts Responsiveness to Kinase InhibitorsCancer Discovery, 2011
- A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)‐induced invasion and metastasis of cholangiocarcinoma cells†Hepatology, 2010
- Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and BortezomibBritish Journal of Cancer, 2010
- Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosisOncogene, 2009
- To kill a tumor cell: the potential of proapoptotic receptor agonistsJournal of Clinical Investigation, 2008
- Azoospermia in mice with targeted disruption of theBrek/Lmtk2(brain-enriched kinase/lemur tyrosine kinase 2) geneProceedings of the National Academy of Sciences, 2006